Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NeuPath Health Inc. (V:NPTH)

Business Focus: Healthcare Facilities & Services (NEC)

Mar 15, 2024 07:30 am ET
NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2023 RESULTS
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months and year ended December 31, 2023. All figures are in Canadian dollars, unless otherwise noted.
Jan 15, 2024 07:30 am ET
NEUPATH ANNOUNCES CLINIC ACQUISITION
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the closing of the acquisition of the assets of SIBI Medical Inc., operating as the London Spine Institute in London, Ontario effective January 12, 2024.
Nov 16, 2023 07:30 am ET
NEUPATH HEALTH REPORTS THIRD QUARTER 2023 RESULTS
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2023. All figures are in Canadian dollars, unless otherwise noted.
Nov 13, 2023 07:30 am ET
NEUPATH HEALTH ANNOUNCES SUCCESSFUL CLOSING OF UPDATED CREDIT FACILITY
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced completion and closing of a new credit facility (“Credit Facility”) with its existing lender Royal Bank of Canada (“RBC”).
Sep 05, 2023 08:52 am ET
NEUPATH SUCCESSFULLY COMPLETES SALE OF CORPORATE-OWNED MEDICAL FACILITY
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update on the sale of its corporate-owned medical facility, which had previously been announced on March 15, 2023.
Aug 17, 2023 07:30 am ET
NEUPATH HEALTH DELIVERS RECORD QUARTERLY REVENUES
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and six months ended June 30, 2023. All figures are in Canadian dollars, unless otherwise noted.
Jun 15, 2023 08:30 am ET
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 14, 2023 and the grant of stock options (“Options”) and restricted share units (“RSUs”). All figures are in Canadian dollars, unless otherwise noted.
May 25, 2023 07:30 am ET
NEUPATH HEALTH DELIVERS STRONG QUARTERLY REVENUES AND IMPROVES CASH POSITION
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months ended March 31, 2023 and the grant of stock options (“Options”). All figures are in Canadian dollars, unless otherwise noted.
May 15, 2023 07:56 am ET
NEUPATH ANNOUNCES THE POSITIVE RESOLUTION OF ITS OUTSTANDING HST MATTER WITH THE CRA
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update regarding its HST objection with the CRA.
May 02, 2023 09:35 am ET
NEUPATH HEALTH ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BROKERED OFFERING OF $1.453 MILLION OF SUBORDINATED AND POSTPONED UNSECURED NON-CONVERTIBLE DEBENTURES
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has closed its previously announced brokered private placement offering of 10% subordinated and postponed unsecured non-convertible debenture units of the Company (the “Units”) for gross proceeds of $1.453 million (the “Offering”).The Offering was led by Bloom Burton Securities Inc. as lead agent and Hampton Securities Ltd. (collectively, the “Agents”).
Apr 18, 2023 07:30 am ET
NeuPath Health to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2023 Bloom Burton & Co. Healthcare Investor Conference.
Apr 11, 2023 05:01 pm ET
NeuPath Health Announces Proposed Brokered Offering of Subordinated and Postponed Unsecured Non-Convertible Debentures of up to $1.4 Million
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced a proposed offering of up to 1,400 units of the Company (the “Units”) pursuant to which NeuPath proposes to raise gross proceeds of up to $1.4 million (the “Offering”). The Offering is being led by Bloom Burton Securities Inc. as lead agent and Hampton Securities Ltd. (collectively, the “Agents”).
Mar 30, 2023 07:30 am ET
NeuPath Health Delivers Record Quarterly Revenues and Opens New Fluoroscopy Suite to Patients
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months and year ended December 31, 2022. All figures are in Canadian dollars, unless otherwise noted.
Mar 21, 2023 07:30 am ET
NeuPath Announces Preliminary Financial Results for Fiscal 2022
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, is pleased to provide an update with selected preliminary unaudited results for the fourth quarter of 2022 and the full year ended December 31, 2022. The Company plans to release its audited fiscal 2022 financial results before markets open on Thursday, March 30, 2023.
Mar 15, 2023 07:30 am ET
NeuPath Sells Corporate-owned Medical Facility
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update on its ongoing focus on operational and balance sheet improvements.
Mar 09, 2023 07:30 am ET
NeuPath CEO Letter to Shareholders
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an open letter to shareholders from NeuPath’s CEO Joe Walewicz. The letter to shareholders is reproduced below.
Nov 17, 2022 07:30 am ET
NeuPath Health Delivers Strong Quarterly Revenues and Opens New Fluoroscopy Suite to Patients
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2022 and the grant of stock options (“Options”) and restricted share units (“RSUs”). All figures are in Canadian dollars, unless otherwise noted.
Oct 19, 2022 07:30 am ET
NeuPath Health Announces Updates to the Board of Directors
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced updates to the Company’s Board of Directors that will continue to support the Company’s leadership team in executing the strategic growth plan.
Sep 30, 2022 07:30 am ET
NeuPath Provides Strategic Update, Announces Board and Executive Changes
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update on leadership changes, as well as its strategic growth plan to significantly accelerate the growth of its best-in-class and coordinated continuum of care for patients across Canada who suffer from pain and pain-related musculoskeletal conditions.
Aug 26, 2022 05:15 pm ET
Neupath Health Announces Issuance of Stock Options
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, announced today that, in relation to the executive changes announced on July 25, 2022, a grant of 965,000 stock options (“Options”) to certain officers of the Company at an exercise price of $0.30 per share, with an expiry date of August 24, 2029. The Options are subject to time-based vesting such that 1/3 vests immediately, 1/3 vests on January 22, 2023 and the remaining Options will vest on July 21, 2023. The terms of the Options grante
Aug 18, 2022 07:30 am ET
NeuPath Health Delivers Record Quarterly Revenues and Adjusted EBITDA Growth Quarter-Over-Quarter
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and six months ended June 30, 2022. All figures are in Canadian dollars, unless otherwise noted.
Aug 09, 2022 07:30 am ET
NeuPath Health Announces Consulting Arrangement to Support Executive Changes
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has entered into a consulting agreement with one of the Company’s directors; Grishanth Ram.
Jul 25, 2022 07:30 am ET
NeuPath Health Unveils Accelerated Growth Plan and Announces Executive Changes
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its strategic growth plan to significantly accelerate the growth of its best-in-class and coordinated continuum of care for patients across Canada who suffer from pain and pain-related musculoskeletal conditions.
Jun 23, 2022 10:32 am ET
NeuPath Health Announces Voting Results From the Annual General and Special Meeting of Shareholders and Issuance of Stock Options and Restricted Share Units
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 22, 2022 and the issuance of stock options and restricted share units (“RSUs”).
May 26, 2022 07:30 am ET
Neupath Health Delivers 9% Revenue Growth in Q1 2022
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months ended March 31, 2022. All figures are in Canadian dollars, unless otherwise noted.
Mar 17, 2022 09:03 pm ET
NeuPath Health Delivers 28% Revenue Growth in Fiscal 2021 and Appoints CFO
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months and year ended December 31, 2021. All figures are in Canadian dollars, unless otherwise noted.
Feb 02, 2022 05:15 pm ET
NeuPath Health Announces Warrant Extension
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that it has received the approval of the TSX Venture Exchange for the extension of the exercise period of a total of 7,195,000 prefunded common share purchase warrants of the Company (the “Prefunded Warrants”), all of which are exercisable at $0.0001 per common share. The Company proposes to extend the expiry dates of the Prefunded Warrants for an additional year from February 23, 2022 to February 23, 2
Nov 30, 2021 07:30 am ET
NeuPath and Central Alberta Orthopedics Collaborate to Build Clinic & Improve Access to Care
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its wholly-owned subsidiary, HealthPointe Medical Centres Ltd. (“HealthPointe”), has entered into a partnership with Central Alberta Orthopedics (“CAO”), a leading provider of multidisciplinary care in musculoskeletal trauma and reconstructive surgery, to open an interdisciplinary pain institute in Red Deer, Alberta. The clinic is expected to be open to patients in May 2022 and ownership of the newly formed corporation is
Nov 12, 2021 07:30 am ET
NeuPath Health Revenue Growth Remains Strong at 26% in Q3 2021
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2021. All figures are in Canadian dollars, unless otherwise noted.
Oct 04, 2021 04:30 pm ET
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
Aug 23, 2021 07:30 am ET
NeuPath and Cynergi Collaborate to Advance Virtual Reality and Remote Pain Management Technology in Treatment of Chronic Pain
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment announced today a Memorandum of Understanding (“MoU”) with Texas-based Cynergi Health Partners (“Cynergi”), a leading multidisciplinary company recognized for clinical excellence and for cutting edge treatment technologies for addiction and psychiatry, to evaluate the effectiveness of Cynergi’s virtual reality (“VR”) program targeting chronic pain management. Rilaxta VRx, Cynergi’s category leading software, will be used in combination wit
Aug 17, 2021 07:30 am ET
NeuPath Closes Acquisition of KumoCare, a Virtual Care Platform
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, is pleased to announce that it has closed the previously announced acquisition of KumoCare.
Aug 12, 2021 07:30 am ET
NeuPath Health Revenue Growth Accelerates to 42% in Q2 2021
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced its financial and operating results for the three and six months ended June 30, 2021. All figures are in Canadian dollars, unless otherwise noted.
Jul 14, 2021 07:30 am ET
NeuPath to Host Investor Webcast on July 21, 2021
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced that it will host a webcast investor presentation on Wednesday, July 21st, 2021 at 2:00 PM ET.
Jun 28, 2021 04:23 pm ET
NeuPath Health Announces Voting Results From the Annual General and Special Meeting of Shareholders
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 25, 2021.
Jun 09, 2021 07:30 am ET
Neupath Health Announces Strategic Acquisition of Virtual Care Business and Management Changes
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced a strategic transaction to acquire KumoCare, a virtual care platform to further expand NeuPath’s virtual care and telemedicine offerings. Prior to the pandemic, patients and their physicians alike preferred an in-person care experience. The care model changed out of necessity in 2020 to bring about virtual care via telemedicine that was both clinic
May 20, 2021 07:30 am ET
NeuPath Health Reports 2021 First Quarter Results
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced its financial and operating results for the three months ended March 31, 2021. All figures are in Canadian dollars, unless otherwise noted.
Apr 20, 2021 07:30 am ET
Neupath Health Provides Corporate Update
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), owner and operator of a network of 13 clinics across Canada that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, is pleased to provide the following updates:
Apr 06, 2021 07:30 am ET
NeuPath Health to Present at Bloom Burton & Co. Healthcare Investor Conference
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today announced Grant Connelly, CEO, will be presenting at the Bloom Burton & Co. Healthcare Investor Conference.
Mar 26, 2021 07:30 am ET
NeuPath Health Reports 2020 and Fourth Quarter Results
NeuPath Health Inc. (TSXV:NPTH) (formerly Klinik Health Ventures Corp.) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today announced its financial and operating results for the three months and year ended December 31, 2020. All figures are in Canadian dollars, unless otherwise noted.
Feb 08, 2021 07:30 am ET
NeuPath Health Acquires HealthPointe Medical Centres, a Leading Interdisciplinary Clinic in Alberta
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, is pleased to announce the acquisition of HealthPointe Medical Centres Ltd. (“HealthPointe”), a leading pain, spine, and sport medicine clinic located in Edmonton, Alberta.
Nov 19, 2020 07:30 am ET
NeuPath Health Reports Third Quarter 2020 Results
NeuPath Health Inc. (TSXV:NPTH) (formerly Klinik Health Ventures Corp.) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today announced its financial and operating results for the three and nine months ended September 30, 2020. All figures are in Canadian dollars, unless otherwise noted.
Oct 20, 2020 09:12 am ET
IIROC Trading Resumption - NPTH
VANCOUVER, BC, Oct. 20, 2020 /CNW/ - Trading resumes in:
Oct 20, 2020 08:58 am ET
NeuPath Health Inc. Announces Increase to Bought Deal Financing to $10.4 Million
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./
Oct 19, 2020 05:09 pm ET
IIROC Trading Halt - NPTH
VANCOUVER, BC, Oct. 19, 2020 /CNW/ - The following issues have been halted by IIROC:
Oct 19, 2020 05:03 pm ET
NeuPath Health Inc. Announces $8 Million Bought Deal Offering of Units
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./
Oct 09, 2020 07:30 am ET
NeuPath Health Announces Participation in Upcoming Events
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, is pleased to announce that the Company has been invited to participate in the inaugural Desjardins Digital Healthcare Conference, hosted by Desjardins Capital Markets. Grant Connelly, NeuPath’s CEO, and Stephen Lemieux, NeuPath’s CFO, will be presenting on November 24, 2020 and will also be participating in one-on-one meetings with investors.
Oct 05, 2020 08:36 am ET
NeuPath Health to Expand Digital Health Capabilities
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, announced today an initiative to expand the Company’s digital health capabilities. Pivot Design Group (“Pivot”) – a leading Toronto boutique strategic design and communications agency specializing in service design, user experience design and communication design – will work with NeuPath, its physicians, healthcare providers, and patients to translate research and insights into proprietary digital health solutions designed to provide chronic pain patients with multi-moda
Sep 01, 2020 05:00 pm ET
NeuPath Health Announces Issuance of Stock Options and Restricted Share Units
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, announced today a grant of 461,080 stock options (“Options”) to directors, officers and certain employees of the Corporation at an exercise price of $0.87 per share, with an expiry date of September 1, 2027. The Options are subject to time-based vesting. Options granted to directors will fully vest on September 1, 2021. Options granted to officers and certain employees of the Corporation will vest annually in equal instalments on each anniversary date from the date of gr
Aug 31, 2020 12:59 pm ET
TMX Group, NeuPath, C-Suite at The Open
TORONTO, Aug. 31, 2020 /CNW/ - Grant Connelly, CEO, NeuPath Health Inc. (TSXV: NPTH), shares his company's story in an interview with TMX Group.
Aug 27, 2020 07:30 am ET
NeuPath Health Reports Second Quarter 2020 Results
NeuPath Health Inc. (TSXV:NPTH) (formerly Klinik Health Ventures Corp.) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today announced its financial and operating results for the three and six months ended June 30, 2020. For further details on the results, please refer to NeuPath’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2020 which are available on the Company’s website (
Aug 18, 2020 01:48 pm ET
Neupath Health Unaware of Any Material Change
NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today at the request of IIROC wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.
Jul 20, 2020 10:44 am ET
NeuPath Health Inc. Virtually Opens The Market
TORONTO, July 20, 2020 /CNW/ - Brady Fletcher, Head of TSX Venture Exchange joined Grant Connelly, Chief Executive Officer, NeuPath Health Inc. (TSXV: NPTH) and his team to celebrate the Company's listing on the TSX Venture Exchange and open the market.
Jul 15, 2020 08:38 am ET
Neupath Health Files First Quarter 2020 Results for 2576560 Ontario Inc
Toronto, Ontario--(Newsfile Corp. - July 15, 2020) - NeuPath Health Inc. (TSXV: NPTH) ("NeuPath" or the "Company"), Canada's largest provider of chronic pain management services, today filed the unaudited interim financial statements for 2576560 Ontario Inc. ("257") for the three months ended March 31, 2020 (the "Interim Financial Statements"). The Company is filing the Interim Financial Statements in accordance with National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102"), as 257 was the "reverse takeover acquirer" (as defined in NI 51-102) of the Company in a court approved plan of arrangement under Section 182 of the Business Corporations Act (Ontario) completed on June 25, 2020 (the "Arrangement").
Jul 03, 2020 04:12 pm ET
IIROC Trading Resumption - NPTH
VANCOUVER, BC, July 3, 2020 /CNW/ - Trading resumes in: